Skip to main content

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

04 Nov 2026 Evaluate
The sales slipped to Rs. 4496.57 millions for the September 2026 quarter as against Rs. 5142.73 millions during the year-ago period.A big decline of -47.00% was reported for the quarter ended September 2026 to Rs. 511.28  millions from Rs. 964.60 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 1045.54 millions from 1569.22 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4496.57 5142.73 -12.56 10912.34 8070.26 35.22 20229.85 14768.37 36.98
Other Income 74.93 17.99 316.51 159.85 96.55 65.56 301.64 205.09 47.08
PBIDT 1045.54 1569.22 -33.37 3356.23 1990.71 68.59 6034.09 3428.08 76.02
Interest 73.05 53.41 36.77 142.77 99.24 43.86 239.45 82.96 188.63
PBDT 972.49 1515.81 -35.84 3213.46 1891.47 69.89 5794.64 4109.16 41.02
Depreciation 287.68 225.39 27.64 553.29 427.26 29.50 917.30 655.42 39.96
PBT 684.81 1290.42 -46.93 2660.17 1464.21 81.68 4877.34 3453.74 41.22
TAX 173.53 325.82 -46.74 675.27 362.53 86.27 1246.29 859.48 45.01
Deferred Tax -5.15 0.70 -835.71 -12.21 -6.26 95.05 -42.55 122.95 -134.61
PAT 511.28 964.60 -47.00 1984.90 1101.68 80.17 3631.05 2594.26 39.96
Equity 129.00 129.01 -0.01 129.00 129.01 -0.01 129.00 129.00 0.00
PBIDTM(%) 23.25 30.51 -23.80 30.76 24.67 24.69 29.83 23.21 28.50
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..